Hoth Financial Statements From 2010 to 2025

HOTH Stock  USD 1.17  0.06  5.41%   
Hoth Therapeutics financial statements provide useful quarterly and yearly information to potential Hoth Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Hoth Therapeutics financial statements helps investors assess Hoth Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Hoth Therapeutics' valuation are summarized below:
Market Capitalization
14.6 M
Earnings Share
(1.27)
We have found one hundred twenty available fundamental trends for Hoth Therapeutics, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Hoth Therapeutics regular fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 5.4 M. The Hoth Therapeutics' current Enterprise Value is estimated to increase to about (4.7 M)
Check Hoth Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hoth Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 668, Interest Expense of 368.8 K or Selling General Administrative of 4.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.61. Hoth financial statements analysis is a perfect complement when working with Hoth Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Hoth Therapeutics Correlation against competitors.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.

Hoth Therapeutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets5.8 M10.9 M3.9 M
Slightly volatile
Other Current Liabilities741.7 K706.4 K231.2 K
Slightly volatile
Total Current Liabilities641.9 K780.5 K365.8 K
Slightly volatile
Total Stockholder Equity10.6 M10.1 M3.8 M
Slightly volatile
Net Tangible Assets11.9 M11.4 M4.4 M
Slightly volatile
Accounts Payable38.9 K40.9 K139.4 K
Slightly volatile
Cash11.2 M10.7 M3.8 M
Slightly volatile
Non Current Assets Total188.9 K106.5 K95.1 K
Slightly volatile
Cash And Short Term Investments5.5 M10.7 M3.7 M
Slightly volatile
Common Stock Total Equity9161.5 K819
Slightly volatile
Common Stock Shares Outstanding1.8 M3.1 M5.4 M
Slightly volatile
Liabilities And Stockholders Equity5.8 M10.9 M3.9 M
Slightly volatile
Non Current Liabilities Total22.5 K23.7 K110.8 K
Pretty Stable
Capital Surpluse29.1 M27.7 M12.4 M
Slightly volatile
Other Stockholder Equity74.5 M71 M23.1 M
Slightly volatile
Total Liabilities767 K810.7 K425.3 K
Slightly volatile
Net Invested Capital10.6 M10.1 M3.8 M
Slightly volatile
Total Current Assets5.6 M10.8 M3.8 M
Slightly volatile
Net Working Capital10.6 M10.1 M3.8 M
Slightly volatile
Common Stock989500692
Slightly volatile
Property Plant Equipment1.8 K9392.4 K
Slightly volatile
Other Current Assets102.3 K121.8 K171.5 K
Slightly volatile
Preferred Stock Total Equity248279304
Slightly volatile
Capital Stock372392840
Pretty Stable
Other Liabilities208 K211.5 K266.2 K
Slightly volatile
Long Term Investments32 K33.7 K316 K
Slightly volatile
Non Current Liabilities Other228 K256.5 K279.7 K
Slightly volatile
Net Receivables40 K45 K49.1 K
Slightly volatile
Short and Long Term Debt Total44.1 K49.6 K54.1 K
Slightly volatile
Short Term Debt23.1 K26 K28.3 K
Slightly volatile

Hoth Therapeutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative4.5 M4.8 M2.9 M
Slightly volatile
Other Operating Expenses7.9 M8.8 M4.2 M
Slightly volatile
Research Development3.6 MM2.3 M
Slightly volatile
Total Operating Expenses8.4 M8.8 M5.6 M
Slightly volatile
Reconciled Depreciation106112867
Slightly volatile
Non Operating Income Net Other63 K119.8 K43.9 K
Slightly volatile
Selling And Marketing Expenses3.4 M3.8 M4.1 M
Slightly volatile

Hoth Therapeutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation106112396
Very volatile
Total Cash From Financing Activities8.8 M13 M6.2 M
Slightly volatile
End Period Cash Flow11.2 M10.7 M3.8 M
Slightly volatile
Change To Netincome1.2 M1.5 M1.9 M
Slightly volatile
Stock Based Compensation185 K194.8 K441.3 K
Pretty Stable
Begin Period Cash Flow3.9 M7.4 M2.6 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
PTB Ratio0.610.6469.2282
Pretty Stable
Book Value Per Share4.272.334.0946
Slightly volatile
Average Payables282.3 K328.8 K295.4 K
Slightly volatile
Capex To Depreciation175185880
Slightly volatile
PB Ratio0.610.6469.2282
Pretty Stable
Payables Turnover0.08220.08658.1699
Pretty Stable
Cash Per Share4.592.454.3521
Slightly volatile
Days Payables Outstanding4.1 K4.4 K48 K
Slightly volatile
Income Quality0.610.970.5314
Slightly volatile
Net Debt To EBITDA57.054.2814.8808
Slightly volatile
Current Ratio12.3415.9817.5617
Slightly volatile
Tangible Book Value Per Share4.272.334.0946
Slightly volatile
Shareholders Equity Per Share4.272.334.0946
Slightly volatile
Debt To Equity0.0050.00560.0061
Slightly volatile
Capex Per Share0.06750.07110.4731
Slightly volatile
Interest Debt Per Share0.01770.01860.2105
Slightly volatile
Debt To Assets0.00460.00520.0057
Slightly volatile
Price Book Value Ratio0.610.6469.2282
Pretty Stable
Days Of Payables Outstanding4.1 K4.4 K48 K
Slightly volatile
Ebt Per Ebit1.121.171.0595
Very volatile
Company Equity Multiplier1.61.241.2656
Pretty Stable
Total Debt To Capitalization0.0050.00560.0061
Slightly volatile
Debt Equity Ratio0.0050.00560.0061
Slightly volatile
Quick Ratio21.3412.524.668
Very volatile
Net Income Per E B T0.810.920.989
Slightly volatile
Cash Ratio10.3815.7516.6479
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.251.161.3577
Slightly volatile
Price To Book Ratio0.610.6469.2282
Pretty Stable
Debt Ratio0.00460.00520.0057
Slightly volatile
Price Fair Value0.610.6469.2282
Pretty Stable

Hoth Therapeutics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.4 M5.6 M53.9 M
Slightly volatile

Hoth Fundamental Market Drivers

Cash And Short Term Investments9.3 M

Hoth Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Hoth Therapeutics Financial Statements

Investors use fundamental indicators, such as Hoth Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Hoth Therapeutics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Cost Of Revenue76.9 K73 K

Currently Active Assets on Macroaxis

When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:
Check out the analysis of Hoth Therapeutics Correlation against competitors.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.27)
Return On Assets
(0.46)
Return On Equity
(0.83)
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.